Home » Topics » Regulatory » Patents

Patents
RSS

Lilly continues to investigate new agents for women's health

Nov. 1, 1996

Low-toxicity antitumor agents described by Ajinomoto

Nov. 1, 1996

Antitumor organotin compounds claimed by Dutch company

Nov. 1, 1996

Cell adhesion inhibitors reported by Sumitomo

Nov. 1, 1996

HHS claims MAb for therapeutic, diagnostic and immunologic applications

Nov. 1, 1996

Antitumor antibody for medulloblastoma Rx claimed by Chugai

Nov. 1, 1996

Polyamine antimetabolites claimed by Ciba-Geigy

Nov. 1, 1996

Takeda discloses vaccine candidates

Nov. 1, 1996

Antiarthritic agents reported by Kaken

Nov. 1, 1996

ADIR investigates COX-2 inhibitors

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...